These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35071012)

  • 1. Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study.
    Davies JC; Husain Z; Day TA; Graboyes EM; Eskander A
    Front Oncol; 2021; 11():808465. PubMed ID: 35071012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Trends in 30-Day Readmission Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Nyirjesy SC; McCrary HC; Zhao S; Judd RT; Farlow JL; Seim NB; Ozer E; Agrawal A; Old MO; Rocco JW; Kang SY; Haring CT
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):133-141. PubMed ID: 38153724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
    Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transoral robotic surgery and transoral laser microsurgery for oropharyngeal squamous cell cancer.
    Sumer BD; Goyal V; Truelson JM; Myers LL
    J Robot Surg; 2013 Dec; 7(4):377-83. PubMed ID: 27001878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Oliver JR; Persky MJ; Wang B; Duvvuri U; Gross ND; Vaezi AE; Morris LGT; Givi B
    Cancer; 2022 Feb; 128(4):685-696. PubMed ID: 34762303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Jackson RS; Stepan K; Bollig C; Sharma RK; Patel M; Massa S; Puram SV; Zevallos JP; Pipkorn P; Zenga J
    Otolaryngol Head Neck Surg; 2021 Nov; 165(5):682-689. PubMed ID: 33752484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
    Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
    Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.
    Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA
    J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T1-T2 stage oropharyngeal squamous cell carcinoma treated with transoral robotic surgery.
    Li H; Zhang X; Chen W; Zhang Q; Li Q; Chen S; Yang Z; Su X; Yan S; Yang A; Song M
    Laryngoscope Investig Otolaryngol; 2023 Feb; 8(1):103-112. PubMed ID: 36846425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.